InsidersTradesSigma
Track the 동화약품 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 동화약품 has published 21 insider filings. The latest transaction was reported on 12 February 2026 (Other). Among the most active insiders: 윤도준. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
21 of 21 declarations
Dongwha Pharmaceutical is a South Korean company specializing in the healthcare and pharmaceutical sector. It is listed on the XKRX market.